Liquidia Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Liquidia Technologies's estimated annual revenue is currently $17.2M per year.
- Liquidia Technologies received $25.5M in venture funding in February 2018.
- Liquidia Technologies's estimated revenue per employee is $155,000
- Liquidia Technologies's total funding is $173.9M.
Employee Data
- Liquidia Technologies has 111 Employees.
- Liquidia Technologies grew their employee count by 41% last year.
Liquidia Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $4.8M | 31 | -6% | N/A | N/A |
#9 | $6.4M | 41 | 3% | N/A | N/A |
#10 | $4.2M | 27 | -18% | N/A | N/A |
What Is Liquidia Technologies?
Liquidia Technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. Our proprietary PRINT technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. PRINT technology is a scalable cGMP compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. Liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. Liquidia is advancing product candidates from its own pipeline. These initial product candidates, LIQ861 and LIQ865, apply the PRINT technology to better drug delivery in inhaled and pain therapeutic areas, respectively. The PRINT technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.
keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power
$173.9M
Total Funding
111
Number of Employees
$17.2M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Liquidia Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operations Officer | Reveal Email/Phone |
2 | Territory Account Manager (PAH) - Houston Territory | Reveal Email/Phone |
3 | U.S. Marketing Director | Reveal Email/Phone |
4 | Director Quality Control | Reveal Email/Phone |
5 | Principal Scientist | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Principal Engineer | Reveal Email/Phone |
8 | Director IT | Reveal Email/Phone |
9 | Regional Business Director | Reveal Email/Phone |
10 | VP Sales | Reveal Email/Phone |
Liquidia Technologies News
The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has...
and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial...
and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial...
A biotechnology company based in the Research Triangle Park has raised $50 million in an initial public offering. Morrisville-based Liquidia Technologies Inc. sold 4.5 million shares at a price of $11 per share. When it initially filed for its IPO, the company had hoped to raise $57.5 million. ...
A biotechnology company based in the Research Triangle Park has filed to raise $57.5 million in an initial public offering, according to a filing Thursday with the Securities and Exchange Commission. Morrisville-based Liquidia Technologies Inc. is a nanotechnology company that designs, develops ...
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.6M | 112 | -1% | N/A |
#2 | $16.2M | 112 | 7% | N/A |
#3 | $33.6M | 116 | 4% | N/A |
#4 | $24.6M | 117 | 7% | N/A |
#5 | $32.4M | 120 | 56% | N/A |
Liquidia Technologies Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2006-06-15 | $6.0M | Undisclosed | Wakefield Group | Article |
| 2007-03-05 | $16.0M | Undisclosed | New Enterprise Associates | Article |
| 2009-08-03 | $7.0M | Undisclosed | Article | |
| 2009-12-18 | $3.0M | Undisclosed | National Institute of Standard | Article |
| 2010-01-20 | $20.0M | C | Canaan Partners | Article |
| 2010-04-21 | $Undisclosed | C | PPD Inc | Article |
| 2014-09-11 | $10.0M | A | Canaan Partners | Article |
| 2018-02-21 | $25.5M | Undisclosed | Article |
Liquidia Technologies Executives
| Name | Title |
|---|---|
| Michael Kaseta | Chief Financial Officer |
| Roger Jeffs | Chief Executive Officer |
| Rajeev Saggar | Chief Medical Officer |
| Neal Fowler | CEO |
| Robert Lippe | Chief Operations Officer |
| Bruce Boucher | President/CFO |
| Tushar Shah | Chief Medical Officer & Head of R&D, Liquidia Technologies |
| Mike Kaseta | Chief Financial Officer |
| Rajeev Saggar | Chief Medical Officer |
| Bruce Boucher | President/CFO |
| Matt Snow | Vice President of Sales |
| Todd Battistoni | Vice President Of Quality |
| Jason Adair | Vice President, Corporate Development & Strategy |
| Jennifer Weidman | Vice President, Global Regulatory Affairs |
| Jason Prabel | Vice President of CMC R&D |
| Gerald O'Brien | Vice President Of Clinical Developement |
| Florina Krawchick | Senior Vice President, Human Resources (Officer) |
| Frank Bartolini | Vice President of Market Access |
| Scott Moomaw | Senior Vice President, Commercial |
| Michael Hunter | Vice President, Manufacturing Operations |
| Celia Reyes | Vice President, People and Culture |
| Jennifer Weidman | Vice President, Global Regulatory Affairs |